Eps Summary of Celyad Oncology SA

Celyad Oncology SA's latest annual eps in 2023 was -0.33 EUR , up 81.77% from previous year.
Celyad Oncology SA's latest quarterly eps in 2024 Q2 was -0.12 EUR , down 0.0% from previous quarter.
Celyad Oncology SA reported an annual eps of -1.81 EUR in 2022, down -6.47% from previous year.
Celyad Oncology SA reported an annual eps of -1.70 EUR in 2021, down -34.92% from previous year.
Celyad Oncology SA reported a quarterly eps of -0.17 EUR for 2023 Q2, down 0.0% from previous quarter.
Celyad Oncology SA reported a quarterly eps of -0.16 EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Eps Chart of Celyad Oncology SA (2023 - 2011)

Historical Annual Eps of Celyad Oncology SA (2023 - 2011)

Year	Eps	Eps Growth
2023	-0.33 EUR	81.77%
2022	-1.81 EUR	-6.47%
2021	-1.70 EUR	-34.92%
2020	-1.26 EUR	44.98%
2019	-2.29 EUR	29.75%
2018	-3.26 EUR	44.37%
2017	-5.86 EUR	-131.62%
2016	-2.53 EUR	26.24%
2015	-3.43 EUR	-40.57%
2014	-2.44 EUR	18.94%
2013	-3.01 EUR	-785.29%
2012	-0.53 EUR	76.39%
2011	-1.44 EUR	0.0%

Year	Eps	Eps Growth
2024 Q2	-0.12 EUR	0.0%
2023 Q2	-0.17 EUR	0.0%
2023 Q4	-0.16 EUR	0.0%
2022 Q4	-1.19 EUR	0.0%
2022 Q2	-0.29 EUR	14.71%
2022 Q1	-0.34 EUR	-142.86%
2022 FY	- EUR	-6.47%
2021 Q4	-0.14 EUR	39.13%
2021 Q2	-0.43 EUR	29.51%
2021 Q3	-0.23 EUR	46.51%
2021 Q1	-0.61 EUR	-274.29%
2021 FY	- EUR	-34.92%
2020 Q2	-1.19 EUR	0.0%
2020 FY	- EUR	44.98%
2020 Q4	0.35 EUR	189.74%
2020 Q3	-0.39 EUR	67.23%
2019 FY	- EUR	31.85%
2019 Q1	-0.57 EUR	64.15%
2019 Q2	-1.34 EUR	-135.09%
2019 Q4	-0.95 EUR	0.0%
2018 Q2	-1.79 EUR	-113.1%
2018 FY	- EUR	42.66%
2018 Q4	-1.59 EUR	0.0%
2018 Q1	-0.84 EUR	80.47%
2017 FY	- EUR	-131.62%
2017 Q4	-4.30 EUR	0.0%
2017 Q2	-1.52 EUR	-3.4%
2017 Q1	-1.47 EUR	-104.17%
2016 FY	- EUR	26.24%
2016 Q2	-1.82 EUR	-188.89%
2016 Q4	-0.72 EUR	0.0%
2016 Q1	-0.63 EUR	55.94%
2015 Q4	-1.43 EUR	-66.28%
2015 FY	- EUR	-40.57%
2015 Q3	-0.86 EUR	59.05%
2015 Q2	-2.10 EUR	-144.19%
2015 Q1	-0.86 EUR	39.44%
2014 FY	- EUR	18.94%
2014 Q1	-0.61 EUR	51.97%
2014 Q4	-1.42 EUR	-132.79%
2014 Q2	-0.99 EUR	-62.3%
2014 Q3	-0.61 EUR	38.38%
2013 Q1	-0.78 EUR	0.0%
2013 Q2	-3.43 EUR	-339.74%
2013 Q3	-0.78 EUR	77.26%
2013 Q4	-1.27 EUR	-62.82%
2013 FY	- EUR	-785.29%
2012 Q3	-0.08 EUR	0.0%
2012 Q2	-0.08 EUR	0.0%
2012 Q1	-0.08 EUR	0.0%
2012 FY	- EUR	76.39%
2012 Q4	-0.78 EUR	-817.65%
2011 Q1	-0.36 EUR	0.0%
2011 Q2	-0.36 EUR	0.0%
2011 Q3	-0.36 EUR	0.0%
2011 Q4	-0.08 EUR	76.39%
2011 FY	- EUR	0.0%
2010 Q4	-0.36 EUR	0.0%

Peer Eps Comparison of Celyad Oncology SA

Name	Eps	Eps Difference
Capstone Therapeutics Corp.	-36.39 USD	99.093%
Skye Bioscience, Inc.	-5.37 USD	93.855%
Santhera Pharmaceuticals Holding AG	5.95 USD	105.546%
Nascent Biotech, Inc.	-0.01 USD	-2362.687%
Qrons Inc.	-0.06 USD	-466.038%
ProtoKinetix, Incorporated	-0.01 USD	-3200.0%
Adynxx, Inc.	- USD	Infinity%
Arch Therapeutics, Inc.	-2.27 USD	85.463%
BioStem Technologies, Inc.	-0.62 USD	46.774%
Regen BioPharma, Inc.	0.26 USD	226.923%
CSL Limited	2.73 USD	112.088%
Northwest Biotherapeutics, Inc.	-0.06 USD	-473.913%
Evofem Biosciences, Inc.	10.35 USD	103.188%
Rebus Holdings, Inc.	-0.03 USD	-928.037%
Burzynski Research Institute, Inc.	-0.01 USD	-3135.294%
Neon Bloom, Inc.	-0.00 USD	-21900.0%
Acro Biomedical Co., Ltd.	-0.26 USD	-26.923%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	99.35%
Nanobac Pharmaceuticals, Incorporated	- USD	Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	-540.777%
SQZ Biotechnologies Company	-2.76 USD	88.043%
Intellipharmaceutics International Inc.	-0.09 USD	-277.574%
Propanc Biopharma, Inc.	-0.02 USD	-1292.405%
Mesoblast Limited	-0.09 USD	-270.37%
Marizyme, Inc.	-1.44 USD	77.083%
Genus plc	0.12 USD	375.0%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	85.837%
Pharming Group N.V.	-0.02 USD	-1949.689%
Therapeutic Solutions International, Inc.	-0.00 USD	-47042.857%
CNBX Pharmaceuticals Inc.	-0.42 USD	21.429%
Nymox Pharmaceutical Corporation	-0.10 USD	-241.969%
ContraFect Corporation	-124.97 USD	99.736%
PsyBio Therapeutics Corp.	-0.04 USD	-685.714%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	-2650.0%
IMV Inc.	-4.37 USD	92.449%
AXIM Biotechnologies, Inc.	-0.04 USD	-832.203%
MultiCell Technologies, Inc.	-0.00 USD	-329900.0%
ONE Bio Corp.	1.43 USD	123.077%
Accustem Sciences Inc.	-0.34 USD	2.941%
RVL Pharmaceuticals plc	-0.58 USD	43.103%
Arno Therapeutics, Inc.	- USD	Infinity%
EV Biologics, Inc.	-0.12 USD	-175.0%
Q BioMed Inc.	-0.08 USD	-322.535%
Emmaus Life Sciences, Inc.	-0.07 USD	-369.417%
Mosaic ImmunoEngineering Inc.	-0.33 USD	-0.0%
Biomind Labs Inc.	-0.02 USD	-1937.037%
American Oriental Bioengineering, Inc.	-781.24 USD	99.958%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	-4359.459%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
Oncotelic Therapeutics, Inc.	-0.02 USD	-1558.291%
GlobeStar Therapeutics Corporation	-0.00 USD	-13650.0%
THC Farmaceuticals, Inc.	-0.00 USD	-41150.0%
Curative Biotechnology, Inc.	-0.01 USD	-3650.0%
GB Sciences, Inc.	-0.00 USD	-7948.78%
Alpha Cognition Inc.	-0.15 USD	-120.0%
HST Global, Inc.	-0.03 USD	-1082.796%
Wesana Health Holdings Inc.	-0.05 USD	-558.683%
Halberd Corporation	-0.00 USD	-329900.0%
Enzolytics Inc.	-0.00 USD	-47042.857%
Agentix Corp.	-0.04 USD	-842.857%
Resverlogix Corp.	-0.01 USD	-2223.944%
Nuo Therapeutics, Inc.	-0.08 USD	-337.666%
MetaStat, Inc.	- USD	Infinity%
argenx SE	-5.16 USD	93.605%
Enzon Pharmaceuticals, Inc.	0.00 USD	25484.615%
Endonovo Therapeutics, Inc.	0.03 USD	1414.741%
RespireRx Pharmaceuticals Inc.	-0.04 USD	-824.37%
GeneThera, Inc.	- USD	Infinity%
Inhibitor Therapeutics, Inc.	-0.02 USD	-1550.0%
AVAX Technologies, Inc.	-0.05 USD	-512.245%
Zenith Capital Corp.	-0.07 USD	-372.103%
Genscript Biotech Corporation	-0.05 USD	-626.872%
Ember Therapeutics, Inc.	-0.01 USD	-5138.095%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	91.247%
WPD Pharmaceuticals Inc.	-0.00 USD	-65900.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	-261.446%
Kadimastem Ltd	-0.78 USD	57.692%
Helix BioMedix, Inc.	-4.70 USD	92.979%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
Oncology Pharma Inc.	- USD	Infinity%
Reve Technologies, Inc.	-0.01 USD	-2673.109%
LadRx Corporation	0.68 USD	148.529%
Cell Source, Inc.	-0.17 USD	-94.118%
Regen BioPharma, Inc.	0.29 USD	213.793%
NovAccess Global Inc.	-0.23 USD	-43.478%
Affymax, Inc.	-0.39 USD	15.385%
Itoco Inc.	-0.01 USD	-4242.105%
Rasna Therapeutics, Inc.	-0.01 USD	-3200.0%
Pathfinder Cell Therapy, Inc.	-0.00 USD	-13100.0%
Mobile Lads Corp.	-0.01 USD	-5792.857%
CytoDyn Inc.	-0.05 USD	-523.819%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	-65900.0%
NanoSphere Health Sciences Inc.	-0.02 USD	-1386.486%
Alseres Pharmaceuticals, Inc.	-153.67 USD	99.785%
SYBLEU INC	-0.02 USD	-1785.714%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	-2223.944%
International Stem Cell Corporation	-0.02 USD	-1912.195%
Bioxytran, Inc.	-0.03 USD	-934.483%
GlobeImmune, Inc.	- USD	Infinity%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	- USD	Infinity%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	-0.00 USD	-329900.0%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	-7.99 USD	95.87%
Adhera Therapeutics, Inc.	-1.18 USD	72.034%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	-0.03 USD	-870.588%
Innovation Pharmaceuticals Inc.	-0.01 USD	-5138.095%
Neutra Corp.	-0.00 USD	-329900.0%
Windtree Therapeutics, Inc.	-94.23 USD	99.65%
PureTech Health plc	-2.38 USD	86.134%
Coeptis Therapeutics, Inc.	-0.83 USD	60.241%
IXICO plc	-0.02 USD	-1252.459%
IntelGenx Technologies Corp.	-0.06 USD	-480.986%
Gelesis Holdings, Inc.	-1.35 USD	75.556%
CSL Limited	5.47 USD	106.033%
Cellectis S.A.	-1.77 USD	81.356%

Global Stocks Search

Celyad Oncology SA (CLYYF)

Eps Summary of Celyad Oncology SA

Annual Eps Chart of Celyad Oncology SA (2023 - 2011)

Historical Annual Eps of Celyad Oncology SA (2023 - 2011)

Peer Eps Comparison of Celyad Oncology SA